showed a trendP = 0.091
PAI-1 showed a trend towards reduced cancer specific survival in PAI-1 high-grade cases (68 versus 83 months; P = 0.091).
PAI-1 showed a trend towards reduced cancer specific survival in PAI-1 high-grade cases (68 versus 83 months; P = 0.091).
Additionally, a nonsignificant trend towards higher PAI-1 levels was found in metastatic disease ( P = 0.153) ( Figure 3(h) ), whereas the uPA levels showed no significant differences between localized and metastatic disease ( Figure 3(g) ).
However, a clear trend towards adverse outcome was found for PAI-1.
However, in our validation set, we only found a weak correlation between budding and PAI-1 with marginal significance.